S0221 Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer

NCT00070564 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

3294

Enrollment

NETWORK

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: pegfilgrastim
DRUG: AC regimen
DRUG: cyclophosphamide
DRUG: doxorubicin hydrochloride
DRUG: paclitaxel

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]